Patents by Inventor Masaaki Ueki

Masaaki Ueki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200015400
    Abstract: ‘Tochigi i37 Go’ is a new variety of strawberry bred by crossbreeding variety ‘Tochigi 32 Go’ and ‘09-48-5’ in 2012. The plant may be used, e.g., for cultivation of fruit for consumption. ‘Tochigi i37 Go’ is a high-quality, high-yielding variety having early maturing and high-yielding characteristic, fruit with a taste similar to those of ‘Tochiotome’, a large fruit size, a firm fruit firmness, and adaptability to forcing culture.
    Type: Application
    Filed: April 5, 2019
    Publication date: January 9, 2020
    Inventors: Kobayashi Yasuhiro, Takashi Shigeno, Takashi Ohashi, Akitsugu Hatakeyama, Kazunari Iimura, Tatsuro Nakanishi, Masaaki Ueki, Akina Toyoda, Asami Nagashima, Yoshinori Saito, Risa Tsurumi, Natsumi Kojima, Yukio Ohashi
  • Patent number: 9237744
    Abstract: A preservative solution for low temperature preservation of animal or human organs and animal or plant tissues or cells contains D-allose. For the human kidney, cells derived from animals or humans, or human or animal sperm and/or ovum and/or fermented ovum, the preservation is conducted at from ?5 to 20° C. For cells derived from animals or humans, or human or animal sperm and/or ovum and/or fermented ovum, the preservation is conducted at a temperature at which to start freezing to ?196° C. A method for the low temperature preservation of an animal or human organ and an animal or plant tissue or cell at a low temperature comprises (a) refluxing or immersing a preservative solution containing D-allose and the organ or the tissue or mixing the cell therewith, and (b) cooling the organ, the tissue or the cell to a low temperature of from ?5 to 20° C.
    Type: Grant
    Filed: May 26, 2005
    Date of Patent: January 19, 2016
    Assignees: NATIONAL UNIVERSITY CORPORATION KAGAWA UNIVERSITY, MATSUTANI CHEMICAL INDUSTRY CO., LTD.
    Inventors: Masaaki Tokuda, Masaaki Ueki, Rikiya Taoka, Yoshiyuki Kakehi, Ken Izumori
  • Patent number: 8420606
    Abstract: A method of utilizing the physiological activity of a rare saccharide, wherein physiological-activity sensitive cells are treated with the rare saccharide to modify the function of the cells. A composition containing, as an active ingredient, a rare saccharide which is introduced into physiological-activity sensitive cells and has an effect of modifying the function of the cells. The cells are human cells. The composition is a functional food, a drug, or a cosmetic. The rare saccharide is a rare saccharide belonging to aldose and/or ketose. The aldose is D-allose, and the cells are selected from the group consisting of cancer-cell proliferation inhibitory activity sensitive cells and active-oxygen production inhibitory activity sensitive cells. The ketose is D-psicose, and the cells are selected from the group consisting of chemokine secretion inhibitory activity sensitive cells, microglia migration inhibitory activity sensitive cells, and hypoglycemic activity sensitive cells.
    Type: Grant
    Filed: January 14, 2011
    Date of Patent: April 16, 2013
    Assignees: Fushimi Pharmaceutical Co., Ltd., Teikoku Seiyaku Co., Ltd., National University Corporation Kagawa University, Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo
    Inventors: Ken Izumori, Masaaki Tokuda, Toshifumi Itano, Osamu Miyamoto, Toshihiko Ishida, Koji Murao, Taizo Tasaka, Gan Muneuchi, Fuminori Yamaguchi, Terukazu Tanaka, Masaaki Ueki, Kazuyuki Hirooka, Tomohiko Taminato, Mohammad A. Hossain, Keiji Tsusaki, Takeo Takahashi, Mitsuhiro Nagata, Yutaka Ishida
  • Publication number: 20110112043
    Abstract: A method of utilizing the physiological activity of a rare saccharide, wherein physiological-activity sensitive cells are treated with the rare saccharide to modify the function of the cells. A composition containing, as an active ingredient, a rare saccharide which is introduced into physiological-activity sensitive cells and has an effect of modifying the function of the cells. The cells are human cells. The composition is a functional food, a drug, or a cosmetic. The rare saccharide is a rare saccharide belonging to aldose and/or ketose. The aldose is D-allose, and the cells are selected from the group consisting of cancer-cell proliferation inhibitory activity sensitive cells and active-oxygen production inhibitory activity sensitive cells. The ketose is D-psicose, and the cells are selected from the group consisting of chemokine secretion inhibitory activity sensitive cells, microglia migration inhibitory activity sensitive cells, and hypoglycemic activity sensitive cells.
    Type: Application
    Filed: January 14, 2011
    Publication date: May 12, 2011
    Applicants: NATIONAL UNIVERSITY CORPORATION KAGAWA UNIVERSITY, MATSUTANI CHEMICAL INDUSTRY CO., LTD.
    Inventors: Ken Izumori, Masaaki Tokuda, Toshifumi Itano, Osamu Miyamoto, Toshihiko Ishida, Koji Murao, Taizo Tasaka, Gan Muneuchi, Fuminori Yamaguchi, Terukazu Tanaka, Masaaki Ueki, Kazuyuki Hirooka, Tomohiko Taminato, Mohammad Akram Hossain, Keiji Tsusaki, Takeo Takahashi, Mitsuhiro Nagata, Yutaka Ishida
  • Patent number: 7906487
    Abstract: A method of utilizing the physiological activity of a rare saccharide, wherein physiological-activity sensitive cells are treated with the rare saccharide to modify the function of the cells. A composition containing, as an active ingredient, a rare saccharide which is introduced into physiological-activity sensitive cells and has an effect of modifying the function of the cells. The cells are human cells. The composition is a functional food, a drug, or a cosmetic. The rare saccharide is a rare saccharide belonging to aldose and/or ketose. The aldose is D-allose, and the cells are selected from the group consisting of cancer-cell proliferation inhibitory activity sensitive cells and active-oxygen production inhibitory activity sensitive cells. The ketose is D-psicose, and the cells are selected from the group consisting of chemokine secretion inhibitory activity sensitive cells, microglia migration inhibitory activity sensitive cells, and hypoglycemic activity sensitive cells.
    Type: Grant
    Filed: May 22, 2003
    Date of Patent: March 15, 2011
    Assignees: Fushimi Pharmaceutical Co., Ltd., Teikoku Seiyaku Co., Ltd., National University Corporation Kagawa University, Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo
    Inventors: Ken Izumori, Masaaki Tokuda, Toshifumi Itano, Osamu Miyamoto, Toshihiko Ishida, Koji Murao, Taizo Tasaka, Gan Muneuchi, Fuminori Yamaguchi, Terukazu Tanaka, Masaaki Ueki, Kazuyuki Hirooka, Tomohiko Taminato, Mohammad Akram Hossain, Keiji Tsusaki, Takeo Takahashi, Mitsuhiro Nagata, Yutaka Ishida
  • Publication number: 20080299535
    Abstract: [Problem] To provide a preservative solution for cells, tissues and organs using a rare sugar and a preservation method using the solution. [Means for Resolution] A preservative solution for cryopreservation of animal or human organs and animal or plant tissues or cells, the solution containing a rare sugar D-allose. A preservative solution for cryopreservation of the human kidney, cells derived from animals or humans, or human or animal sperm and/or ovum and/or fermented ovum in which the cryopreservation is conducted at from ?5 to 20° C. A preservative solution for cryopreservation of cells derived from animals or humans, or human or animal sperm and/or ovum and/or fermented ovum in which the cryopreservation is conducted at a temperature at which to start freezing to ?196° C.
    Type: Application
    Filed: May 26, 2005
    Publication date: December 4, 2008
    Applicant: NATIONAL UNIVERSITY CORPORATION KAGAWA UNIVERSITY
    Inventors: Masaaki Tokuda, Masaaki Ueki, Rikiya Taoka, Yoshiyuki Kakehi, Ken Izumori
  • Publication number: 20050245459
    Abstract: A method of utilizing the physiological activity of a rare saccharide, wherein physiological-activity sensitive cells are treated with the rare saccharide to modify the function of the cells. A composition containing, as an active ingredient, a rare saccharide which is introduced into physiological-activity sensitive cells and has an effect of modifying the function of the cells. The cells are human cells. The composition is a functional food, a drug, or a cosmetic. The rare saccharide is a rare saccharide belonging to aldose and/or ketose. The aldose is D-allose, and the cells are selected from the group consisting of cancer-cell proliferation inhibitory activity sensitive cells and active-oxygen production inhibitory activity sensitive cells. The ketose is D-psicose, and the cells are selected from the group consisting of chemokine secretion inhibitory activity sensitive cells, microglia migration inhibitory activity sensitive cells, and hypoglycemic activity sensitive cells.
    Type: Application
    Filed: May 22, 2003
    Publication date: November 3, 2005
    Applicants: Fushimi Pharmaceutical Co. Ltd., Teikoku Seiyaku Co. Ltd., Kagawa University, Shikoku Research Institute Incorporated, Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo
    Inventors: Ken Izumori, Masaaki Tokuda, Toshifumi Itano, Osamu Miyamoto, Toshihiko Ishida, Koji Murao, Taizo Tasaka, Gan Muneuchi, Fuminori Yamaguchi, Terukazu Tanaka, Masaaki Ueki, Kazuyuki Hirooka, Tomohiko Taminato, Mohammad Hossain, Keiji Tsusaki, Takeo Takahashi, Mitsuhiro Nagata, Yutaka Ishida
  • Patent number: 6451971
    Abstract: Physiologically active peptides possessing cell adhesion inhibitory activity are provided. A physiologically active peptide of this invention is characterized by possessing cell adhesion inhibitory activity and comprising 30 amino acid residues or less, as well as by having an amino acid sequence of the formula: Gly Leu Lys Pro Gly Val Asp X1 Thr Ile Thr X2 X3 Ala X4 wherein X1 represents Tyr or Ala; X2 represents Val or Ala; X3 represents Tyr or Ala; and X4 represents Val or Ala.
    Type: Grant
    Filed: March 16, 2000
    Date of Patent: September 17, 2002
    Assignee: Hisamitsu Pharmaceutical Co., Ltd.
    Inventors: Katsuhiko Akiyama, Takeshi Goto, Fumio Fukai, Masaaki Ueki
  • Patent number: 6189025
    Abstract: A communication network comprised of communication paths of server layers formed hierarchically by communication paths of client layers, wherein the state of control of the communication paths of a layer being controlled is independently managed in terms of both (i) an administrative state and (ii) a subordinate state indicating influence from communication paths of a server layer, the administrative state of the communication paths of the layer being controlled is changed according to the control for setting and releasing the communication paths, and the subordinate state of the communication paths of a client layer influenced by the change of the administrative state of the communication paths is changed accordingly. At this time, when a subordinate state has already been influenced by a state of control of the communication paths of a server layer, the processing for management is terminated.
    Type: Grant
    Filed: July 14, 1998
    Date of Patent: February 13, 2001
    Assignee: Fujitsu Limited
    Inventors: Takao Ogura, Yasuki Fujii, Kohei Iseda, Takafumi Chujo, Masaaki Ueki
  • Patent number: 6166873
    Abstract: A recording and/or reproducing apparatus for recording and/or reproducing digital audio signal on a recording medium such as a magnetic tape, which includes a recording and/or reproducing unit, an analog-to-digital convertor, a decimation filter, and noise shaper. The recording and/or reproducing unit records and/or reproduces signal on a recording medium at a speed double relative moving speed of a head and the recording medium at least. The analog-to-digital convertor converts input analog audio signal into digital signal with a sampling frequency which is above the audio frequency band, and sufficiently higher than the maximum frequency capable of recording by the recording and/or reproducing unit. The decimation filter reduces the sampling frequency of the digital signal output from the analog-to-digital convertor, and converts it into digital signal of m-bit (m>n).
    Type: Grant
    Filed: June 9, 1999
    Date of Patent: December 26, 2000
    Assignee: Sony Corporation
    Inventors: Gen Ichimura, Masayoshi Noguchi, Yuichi Inomata, Masaaki Ueki, Makoto Yamada
  • Patent number: 5999347
    Abstract: A recording and/or reproducing apparatus for recording and/or reproducing digital audio signal on a recording medium such as a magnetic tape, which includes a recording and/or reproducing unit, an analog-to-digital convertor, a decimation filter, and noise shaper. The recording and/or reproducing unit records and/or reproduces signal on a recording medium at a speed double relative moving speed of a head and the recording medium at least. The analog-to-digital convertor converts input analog audio signal into digital signal with a sampling frequency which is above the audio frequency band, and sufficiently higher than the maximum frequency capable of recording by the recording and/or reproducing unit. The decimation filter reduces the sampling frequency of the digital signal output from the analog-to-digital convertor, and converts it into digital signal of m-bit (m>n).
    Type: Grant
    Filed: April 9, 1997
    Date of Patent: December 7, 1999
    Assignee: Sony Corporation
    Inventors: Gen Ichimura, Masayoshi Noguchi, Yuichi Inomata, Masaaki Ueki, Makoto Yamada
  • Patent number: 5363101
    Abstract: Analog audio signals supplied via an analog signal input terminal 1 are translated in parallel via a first .DELTA..SIGMA. modulator 2 and a second .DELTA..SIGMA. modulator 3 into digital audio data which are summed together by an additive node 4. The resulting sum data is attenuated in level by an attenuator 5 and translated by a decimation filter 6 into audio data having a predetermined number of bits and resulting audio data is outputted via an audio data output terminal 7. There is no necessity of providing a decimation filter for each .DELTA..SIGMA. modulator, so that the number of components may be reduced and the circuit may be simplified in construction to lower production costs. Besides, there is no necessity of re-quantizing the audio data at an output stage so that no quantization noise is produced to enable the S/N ratio to be improved by a theoretical value of 3 dB.
    Type: Grant
    Filed: September 7, 1993
    Date of Patent: November 8, 1994
    Assignee: Sony Corporation
    Inventor: Masaaki Ueki
  • Patent number: 5148168
    Abstract: A digital-to-analog converter utilizing a PWM system for converting input digital data to PWM signals and finally to an analog signal divides the sampling period of the input digital data into an even number of sampling periods and produces PWM signals with equal pulse widths corresponding to the input digital data each divided sampling period, whereby a simple structure is provided to reduce harmonic distortion and obtain a high quality analog signal.
    Type: Grant
    Filed: April 30, 1991
    Date of Patent: September 15, 1992
    Assignee: Sony Corporation
    Inventors: Toshihiko Masuda, Masaaki Ueki
  • Patent number: 5073778
    Abstract: A signal processing apparatus reduces the quantization noise by using so-called noise shaping circuits. The input signal may be audio or video signals. One of the noise shaping circuits is supplied with a signal which is the relative addition of the input signal and a dither while the other noise shaping circuit is supplied with a signal which is the relative subtraction of the input signal and the dither. The signal components of the outputs of the noise shaping circuits are effectively combined to cancel the dither components to produce an output with an improved S/N ratio. A plurality of such signal processing apparatus may be arranged in parallel, in which case different dithers are used in the respective signal processing apparatus and the outputs of the respective signal processing apparatus are combined to further improve the S/N ratio.
    Type: Grant
    Filed: October 30, 1989
    Date of Patent: December 17, 1991
    Assignee: Sony Corporation
    Inventors: Masaaki Ueki, Nobuyuki Yasuda, Toshihiko Masuda
  • Patent number: 3937718
    Abstract: An improved and novel process for the preparation of a carboxylic acid ester which comprises reacting a carboxylic acid with an alcohol or a sulfenic acid ester thereof in the presence of a tertiary phosphine and a disulfide of a mercaptoheterocyclic compound containing a nitrogen-carbon double bond with which the disulfide linkage is conjugated.
    Type: Grant
    Filed: November 17, 1970
    Date of Patent: February 10, 1976
    Assignee: Sankyo Company Limited
    Inventors: Teruaki Mukaiyama, Masaaki Ueki, Rei Matsueda, Hiroshi Maruyama
  • Patent number: PP32077
    Abstract: ‘Tochigi i37 Go’ is a new variety of strawberry bred by crossbreeding variety ‘Tochigi 32 Go’ and ‘09-48-5’ in 2012. The plant may be used, e.g., for cultivation of fruit for consumption. ‘Tochigi i37 Go’ is a high-quality, high-yielding variety having early maturing and high-yielding characteristic, fruit with a taste similar to those of ‘Tochiotome’, a large fruit size, a firm fruit firmness, and adaptability to forcing culture.
    Type: Grant
    Filed: April 5, 2019
    Date of Patent: August 18, 2020
    Assignee: TOCHIGI PREFECTURE
    Inventors: Yasuhiro Kobayashi, Takashi Shigeno, Takashi Ohashi, Akitsugu Hatakeyama, Kazunari Iimura, Tatsuro Nakanishi, Masaaki Ueki, Akina Toyoda, Asami Nagashima, Yoshinori Saito, Risa Tsurumi, Natsumi Kojima, Yukio Ohashi